“Desipramine DMI ), a tricyclic antidepressant and norepinephrine (NE) reuptake blocker, is reported to induce ACTH and cortisol release acutely in humans, probably by facilitating central NE neurotransmission.”
“This is the first human study to suggest an inhibitory effect of DMI on central noradrenergic control of ACTH release.”